Valiant Laboratories Limited
Incorporated in 1980, Valiant Laboratories Limited is a pharmaceutical ingredient manufacturing company in India having focuses on manufacturing Paracetamol.
What Valiant files
- Others61
- Board Meeting17
- Important12
- Results5
- Updates4
- Credit Ratings3
Valiant Laboratories' board has approved the audited financial results for the quarter ended June 30, 2026. Consolidated Revenue hit ₹115.29 Cr, with Net Profit at ₹21.10 Cr. EPS for the quarter stands at ₹3.89.
Valiant Labs has announced its board approved audited consolidated financial results for Q4FY26 and FY26. Q4 revenue was Rs 91.98 Cr with a net profit of Rs 1.76 Cr. For the full year, revenue hit Rs 237.47 Cr, but the company reported a net loss of Rs 3.27 Cr.
Valiant Labs' board has appointed Rajesh Chheda & Co. as Internal Auditors and Ketki D Visariya & Co. as Cost Auditors for FY 2026-27. Key appointments setting the stage for the new financial year.
Valiant Labs' board has approved audited consolidated financial results. Q4 revenue hit ₹91.98 Cr with a net profit of ₹1.76 Cr. For the full year, revenue was ₹237.47 Cr, but the company reported a net loss of ₹3.27 Cr.
Valiant Laboratories' board has approved its Q3 FY26 consolidated financial results. Revenue from operations stood at ₹5.25 Cr, while the company reported a net loss of ₹7.06 Cr. EPS was ₹(1.30).